SCHEMBL4551737

SCHEMBL4551737

O=C(O)c1ccccc1-c1cnno1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 3/20 0.54
USP2 O75604 2/20 0.54
TSHR P16473 1/20 0.54
POLB P06746 5/20 0.51
LMNA P02545 1/20 0.51
RAB9A P51151 5/20 0.44
NPC1 O15118 4/20 0.44
KMT2A Q03164 4/20 0.44
GAA P10253 2/20 0.44
ALOX15 P16050 1/20 0.43
MYC P01106 1/20 0.42
MEN1 O00255 3/20 0.41
FAAH O00519 1/20 0.41
PTP4A3 O75365 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX12 P18054 1/20 0.41
HNF4A P41235 1/20 0.40
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3673661 0.85 BCAT2 (0.49) KDM4EALDH1A1USP2TSHRPOLB
SCHEMBL4551736 0.79 ALDH1A1 (0.37) KDM4EALDH1A1USP2TSHRRAB9A
SCHEMBL3674767 0.76 MAPK1 (0.48) ALDH1A1TSHRPOLBLMNARAB9A
SCHEMBL2883986 0.76 SMN1; SMN2 (0.47) ALDH1A1TSHRLMNARAB9ANPC1
SCHEMBL797912 0.76 KDM4E (0.46) KDM4EALDH1A1TSHRLMNANPC1
SCHEMBL11102271 0.74 KDM4E (0.55) KDM4EALDH1A1USP2TSHRPOLB
SCHEMBL30005971 0.72 KDM4E (0.50) KDM4EALDH1A1USP2TSHRPOLB
SCHEMBL3716310 0.72 KDM4E (0.50) KDM4EALDH1A1USP2TSHRPOLB
SCHEMBL36145 0.72 ALDH1A1 (0.72) KDM4EALDH1A1POLBLMNAKMT2A
SCHEMBL30028907 0.72 ALDH1A1 (0.72) KDM4EALDH1A1POLBLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019243971-A1 NOVEL COMPOUNDS AND THEIR METHODS OF USE THEREOF FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) 2019-12-26 WO claimed
EP-2970313-A1 SUBSTITUTED 7-AZABICYCLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2016-01-20 EP disclosed
WO-2014159591-A1 SUBSTITUTED 7-AZABICYCLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-02 WO disclosed
EP-2079466-A2 SUBSTITUTED INDOLE COMPOUNDS SmithKline Beecham Corporation (US) 2009-07-22 EP disclosed
WO-2008042571-A2 SUBSTITUTED INDOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-04-10 WO disclosed
US-4166732-A Oxadiazol-5-yl-benzoates MONSANTO COMPANY (US) 1979-09-04 US disclosed
US-4166732-A Oxadiazol-5-yl-benzoates MONSANTO COMPANY (US) 1979-09-04 US disclosed
US-4166732-A Oxadiazol-5-yl-benzoates MONSANTO COMPANY (US) 1979-09-04 US disclosed